medigraphic.com
ISSN 2992-779X (Electronic)
ISSN 2007-6452 (Print)

2014, Number 1

<< Back Next >>

Investigación en Discapacidad 2014; 3 (1)

Biomaterials: A key resort in repair of spinal cord damage

Parra-Cid C, Tiscareño-Pérez A, Gómez-García R

Language: Spanish
References: 58
Page: 25-32
PDF size: 218.39 Kb.


ABSTRACT

Injury of spinal cord is a devastating condition affecting some 12,000 people yearly. A major impact is produced on personal, familiar and social life as well as in working ability of patients, their economy and their general health. Must common etiology of injury is due to trauma such as vehicle accidents, falls from a height, working place and sports accidents and gun-shot. There is still not available effective treatment in regenerating spinal cord injuries, however, tissue-engineering can be an alternative resource intended to achieve regeneration of spinal cord tissue by employing biomaterials, casting a scaffold or support for cells, aiming to allow axonal growth and restoring neural continuity inside the injured spinal cord. In spite of the overwhelming amount of investigation on this matter, only most reliable and available biomaterials are reviewed here. Main details and highlights of reviewed biomaterials are described and compared for a judgment of the potential benefits for their application in the near future.


REFERENCES

  1. 1.Discapacinet. Prevención de discapacidad por lesión medular [Documento en Internet]. Disponible en: http: //www.ediscapacinet.gob.mx/images/stories/Liferay/discapacinet/salud_rehabilitacion/PDF/lesiones_medulares.pdf

  2. 2.Xiong Y, Ji-Xiang Z, Zheg-Yu F et al. Coseeded Schwann cells myelinate neuritis from differentiated neural stem cells in neurotrophin-3-loaded PLGA carriers. Int J Nanomedicine. 2012; 7: 1977-1989.

  3. 3.Cigognini D et al. Evaluation of early and late effects into the acute spinal cord injury of an injectable functionalized self-assembling scaffold. PLoS ONE 2011; 6: e19782.

  4. 4.Cheol J, Hyun D, Jin S, Eun H y Yeon S. Epidemiologic changes of patients with spinal cord injury. Ann Rehabil Med. 2013; 37: 50-56.

  5. 5.Jiménez-Ávila J, Calderón-Granados A, Bitar-Alatorre W. Costo directo de las lesiones en la columna. Cir Cir. 2012; 80: 435-441.

  6. 6.University of Alabama. UAB model SCI system. Spinal cord injury facts and figures at a glance. [Documento en Internet]. Disponible en: https: //www.nscisc.uab.edu/PublicDocuments/fact_figures_docs/Facts%202013.pdf.

  7. 7.Freire MAM. Pathophysiology of neurodegeneration following traumatic brain injury. W Indian Med J. 2012; 61: 751-755.

  8. 8.Shechter R, Raposo C, London A, Schwartz M. The glial scar-monocyte interplay: A pivotal resolution phase in spinal cord repair. PLoS ONE. 2011; 6: e27969.

  9. 9.Huang AP, Black PM. Common Neurosurgical Conditions. En: Lawry GV, McKean SC, Matloff J, Ross JJ, Dressler DD, Brotman DJ, Ginsberg JS. Principles and Practice of Hospital Medicine. McGraw-Hill; 2012: p. 425-432.

  10. 10.Kessler JA. Applications of Stem Cell Biology in Clinical Medicine. En: Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J. Harrison’s Principles of Internal Medicine. McGraw-Hill; 2012: p. 543-546.

  11. 11.Drury L. y Mooney D. Hydrogels for tissue engineering: scaffold design variables and applications. Biomaterials. 2003; 24: 4337-4351.

  12. 12.Brandi F, Sommer F, Goepferich A. Rational design of hydrogels for tissue engineering: impact of physical factors on cell behavior. Biomaterials. 2007; 28: 134-146.

  13. 13.Mata A et al. Athree-dimensional scaffold with precise micro-architecture and surface micro-textures. Biomaterials. 2009; 30: 4610-4617.

  14. 14.Mitragotri y Lahann J. Physicalapproachesto biomaterial design. Nat Mater. 2009; 15: 15-23.

  15. 15.Carvalho J, Herthel P, Assis D, Miranda A. Innovative strategies for tissue engineering. In: Rosario Pignatello. Advances in biomaterials science and biomedical applications. INTECH; 2013: p. 295-313.

  16. 16.Wang X. Overview on biocompatibilities of implantable biomaterials. In: Rosario Pignatello. Advances in biomaterials science and biomedical applications. INTECH, 2013: p. 111-155.

  17. 17.Palakurthi S, Yellepeddi V, Kumar A. Nanocarriers for cytosolic drug and gene delivery in cancer therapy. In: Sylwia Olsztynska. Biomedical engineering, trends, research and technologies. INTECH; 2013: p. 245-272.

  18. 18.Jain A, Bellamkonda R. Nano- and micro-technology to spatially and temporally control proteins for neural regeneration. In: Mauro Ferrari, Tejal Desai, Sangeeta Bhatia. Therapeutic micro/nanotechnology. Springer. 2007; p. 3-22.

  19. 19.Wong J, Leach J, Brown X. Balance of chemistry, topography, and mechanics at the cell-biomaterial interface: issues and challenges for assessing the role of substrate mechanic on cell response. Surf Sci. 2004; 570: 119-133.

  20. 20.Gros T, Sakamoto J, Blesch A, Havton L, Tuzynski M. Regeneration of long-tract axons through sites of spinal cord injury using template agarose scaffolds. Biomaterials. 2010; 31: 6719-6729.

  21. 21.Gao M et al. Templated agarose scaffolds for the support of motor axon regeneration into sites of complete spinal cord transection. Biomaterials. 2013; 34: 1529-1536.

  22. 22.Ashton R, Banerjee A, Punyani S, Schaffer D, Kane R. Scaffolds based on degradable alginate hydrogels and poly(lactide-co-glycolide) microspheres for stem cell culture. Biomaterials. 2007; 28: 5518-5525.

  23. 23.okrywczynska M, Drewa T, Jundzill A, Lysik J. Alginate is not a good material for growth of rapidly proliferating cells. Transplant Proc. 2008; 40: 1664-1667.

  24. 24.Palma B et al. Preparation, modification and characterization of alginate hydrogel with nano-/microfibers: a new perspective for tissue engineering. Biomed Res Int [Internet]. 2013; 2013: 307602. doi: 10.1155/2013/307602. Epub 2013 Jun 5. Available in: http: //dx.doi.org/10.1155/2013/307602

  25. 25.Prang P. et al. The promotion of oriented axonal regrowth in the injured spinal cord by alginated-based anisotropic capillary hydrogels. Biomaterials. 2006; 27: 3560-3569.

  26. 26.Cheema U, Ananta M, Mudera V. Collagen: applications of natural polymer in regenerative medicine. In: Daniel Eberli Ed. Regenerative medicine and tissue engineering-cells and biomaterials. INTECH; 2011; p. 287-300.

  27. 27.Cholas R, Hsu H, Spector M. The reparative response to cross-linked collagen-based scaffold in a rat spinal gap model. Biomaterials. 2012; 33: 2050-2059.

  28. 28.Le Bao T, Minh T, Nguyen D, Minh D. Naturally derived biomaterials: preparation and application. In: Jose A. Andrades. Regenerative medicine and tissue engineering. INTECH; 2013: p. 247-274.

  29. 29.Liu T, Houle J, XuJ, Chan B, Chew S. Nanofibrus collagen nerve conduits for spinal cord repair. Tissue Eng 2012; 18: 1057-1066.

  30. 30.Masand S, Perron I, Schanchner M, Shreiber D. Neural cell type-specific responses to glycomimetic functionalized collagen. Biomaterials. 2012; 33: 790-797.

  31. 31.Oseni A, Butler P, Seifalian A. Rapid production of autologus fibrin hydrogels for cellular encapsulation in organ regeneration. In: Joydeep Basu, W Ludlow. Organ regeneration: methods and protocols. Springer; 2013: p. 145-152.

  32. 32.Sharp K et al. Salmon fibrin treatment of spinal cord injury promotes functional recovery and density of serotoninergic innervation. Exp Neurol. 2012; 235: 345-356.

  33. 33.Willerth S, Aredas K, Gottlieb D, Sakiyama-Elbert S. Optimization of fibrin scaffold for differentiation of murine embryonic stem cells into neural lineage cells. Biomaterials. 2006; 27: 5990-6003.

  34. 34.Johnson P, Tatara A, Shiu A, Sakiyama-Elbert S. Controlled release of neurotrophin-3 and platelet derived growth factor form fibrin scaffolds containing neural progenitor cells enhances survival and differentiation in to neurons in sub acute model of SCI. Cell Transplant. 2010; 19: 89-101.

  35. 35.Johnson P, Parker S, Sakiyama-Elbert S. Fibrin-based tissue engineering scaffolds enhance neural fiber sprouting and delays the accumulation of reactive astrocytes at the lesion in a sub acute model of spinal cord injury. J Biomed Mater Res. 2010; 92: 152-163.

  36. 36.Moshayedi P, Carmichael S. Hyaluronan, neural stem cells and tissue reconstruction after acute ischemic stroke. Biomatter. 2013; 3: e23863.

  37. 37.Zhang H et al. Implantation of neuronal stem cells embedded in hyaluronic acid and collagen composite conduit promotes regeneration in a rabbit facial nerve injury model. J Transl Med. 2008; 6: 67.

  38. 38.Preston M, Sherma L. Neural stem cell niches; critical roles for the hyaluronan-based extracelular matrix in neural stem cell proliferation and differentiation. Front Biosci. 2012; 3: 1165-1179.

  39. 39.Hou S et al. The enhancement of cell adherence and inducement of neurite outgrowth of dorsal root ganglia co-cultured with hyaluronic acid hydrogels modified with Nogo-66 receptor antagonist in vitro. Neuroscience. 2006; 137: 519-529.

  40. 40.Austin J et al. The effects of intrathecal injection of a hyaluronan-based hydrogel on inflammation, scarring and neuro behavioral outcomes in a rat model of severe spinal cord injury associated with arachnoiditis. Biomaterials. 2012; 33: 4555-4564.

  41. 41.Luo J, Shi R. Polyethylene glicol inhibits apoptotic cell death following traumatic spinal cord injury. Brain Res. 2007; 1115: 10-16.

  42. 42.Duerstock B, Borgens R. Three-dimensional morphometry of spinal cord injury following polyethylene glicol treatment. J Exp Biol. 2001; 2002: 13-24.

  43. 43.Koob A, Colby J, Borgens R. Behavioral recovery form traumatic brain injury after membrane reconstruction using polyethyleneglycol. J Biol Eng. 2008; 2: 9.

  44. 44.Kouzhaei S, Mousavidoust S, Mobasher H. Protective effect of low molecular weight polyethylene glycol on the repair of the experimentally damaged neural membranes in rat spinal cord. Neurol Res. 2013; 35: 415-423.

  45. 45.Borgens R, Shi R. Behavioral recovery from spinal cord injury following delayed application of polyethyleneglycol. J Exp Biol. 2002; 205: 1-12.

  46. 46.Woerly S. Restorative surgery of the central nervous system by means of tissue engineering using nuerogel implants. Neurosurg Rev. 2000; 23: 59-77.

  47. 47.Madigan N, McMahon S, O’Brien T, Yaszemski M, Windebank A. Current tissue engineering and novel therapeutic approaches to axonal regeneration following spinal cord injury using polymer scaffolds. Resp Physiol Neurobi. 2009; 169: 183-199.

  48. 48.Olson H et al. Neural stem cell- and Schwann cell- loaded biodegradable polymer scaffolds support axonal regeneration in the transected spinal cord. Cell Tissue Eng. 2009; 15: 1797-1805.

  49. 49.Hurtado A et al. Robust CNS regeneration after complete spinal transaction using aligned poly-L-lactic acid microfibers. Biomaterials. 2011; 32: 6068-6079.

  50. 50.Hsu A, Chan S, Chiang C, Chi-Chang C, Jiang C. Peripheral nerve regeneration using a micro porous polylactic acid asymmetric conduit in a rabbit long-gap sciatic nerve transaction model. Biomaterials. 2011; 32: 3764-3775.

  51. 51.Waitayawinyu T et al. A comparison of poly glycolic acid versus type 1 collagen bioabsorbable nerve conduits in a rat model: an alternative to autografting. J Hand Surg. 2007; 32: 1521-1529.

  52. 52.Joosten E. Biodegradable biomatrices and bridging the injured spinal cord: the corticospinal tract as a proof of principle. Cell Tissue Res. 2012; 349: 375-395.

  53. 53.Corning Incorporation. Corning Matrigel® matrix [Documento en Internet]. Disponible en: http: //www.corning.com/lifesciences/surfaces/en/matrigel.aspx

  54. 54.Kohen N, Little L, Healy K. Characterization of matrigel interfaces during defined human embryonic stem cell culture. Bio Interphases. 2009; 4: 69-79.

  55. 55.Kempton L et al. Assessment of axonal growth into collagen nerve guides containing VEGF transfected stem cells in matrigel. Anat Rec. 2009; 292: 214-224.

  56. 56.Perticini V, Amendola J, Decherchi P. The use of poly (N-[2-hidroxypropyl]-methacrylamide) hydrogel to repair a T10 spinal cord hemisection in rat: a behavioral, electrophysiological and anatomical examination. ASN Neuro. 2013; 5: 149-166.

  57. 57.Zhoong Y, Bellamkonda R. Biomaterials for central nervous system. JR Soc. 2008; 5: 957-975.

  58. 58.Yessine M-A, Lafleur M, Meier C, Petereit H-U, Leroux J-C. Characterization of the membrane-destabilizing properties of different pH- sensitive Methacrylic acid copolymers. Biochim Biophys Acta. 2003; 1613: 28-38.




2020     |     www.medigraphic.com